|
August 2008 Educational Meeting
“Accepting the Challenge:
Providing the Best Care for People with Dementia”
En Español
Comprendiendo la Enfermedad
de Alzheimer
 All Meetings & Events
|
Core Meetings
Understanding Dementia
Family Caregiver Workshops
Legal and Financial Planning & Medicaid Home Care Seminar
Easing the Transition from Home
to a Residential Care Facility |
|
 |
A nationwide assistance program for individuals with Alzheimer's and related dementias that also provides Access to vital medical information.
Learn more | Enroll Online |
| |
 |
 |
MemoryWorks
Two-hour sessions of brain stimulating exercises.
Learn More |
 |
Here & Now
A weekly social group for people with early-stage dementia.
Learn More |
|
| |
| |
|
| Breaking News From The ICAD 2008 Conference |
ICAD 2008 took place in the Alzheimer's Association hometown of Chicago, and was the largest group of Alzheimer researchers ever convened with nearly 5,400 participants. We announced in Chicago that ICAD will now become an annual event to keep pace with the rapidly changing Alzheimer research field.
- Alzheimer's Association, National
Read the entire article here
|
| Alzheimer's disease supersedes diabetes as sixth leading cause of death in the United States |
Alzheimer's disease is now the sixth-leading cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics.
- Alzheimer's Association, National
Read the entire article here
|
| Alzheimer's clue found in specific plaque |
Researchers have uncovered a new clue to the cause of Alzheimer's disease. The brains of people with the memory-robbing form of dementia are cluttered with a plaque made up of beta-amyloid, a sticky protein. But there long has been a question whether this is a cause of the disease or a side effect. New research, for the first time, showed the effect of a particular type of beta-amyloid in damaging the brain.
- Associated Press
Read the entire article here
|
| Myriad Genetics ends development of Flurizan |
Biotechnology company Myriad Genetics Inc. said Monday it will end development of Alzheimer's treatment candidate Flurizan after the drug failed to meet goals of an 18-month, late-stage trial. Patients taking Flurizan didn't show better improvement in cognition and day-to-day activities than those taking a placebo.
- Associated Press
Read the entire article here
|
| Doctors Say Medication Is Overused in Dementia |
The use of antipsychotic drugs to tamp down the agitation, combative behavior and outbursts of dementia patients has soared, especially in the elderly. Sales of newer antipsychotics like Risperdal, Seroquel and Zyprexa totaled $13.1 billion in 2007, up from $4 billion in 2000, according to IMS Health, a health care information company.
- NYTimes Online
Read the entire article here
|
| New drug helps some people with Alzheimer's |
Initial results from a study of an experimental drug to treat Alzheimer's disease called bapineuzumab showed that the treatment appears to be effective in some patients.
- The Wall Street Journal
Read the entire article here
|
| Help Increase Awareness and Honor Your Friends and Family with AD - Contribute Photos |
Honor your Friends and Family. We have a really beautiful opportunity for you all to honor your parents, friends, sisters, brothers who have been impacted by Alzheimer's & Parkinson's disease. If you've personally been impacted by Alzheimer's or Parkinson's this is a great way to honor your own life as well.
- NYC Chapter
Read the entire article here
|
| View all news... |
|
| |
|
Help raise $10,000 for our 
Thank Your Pharmacist 
